[5] Active Duty Service Members $0 copay at all points of service military pharmacies, retail network, and home delivery
iu tr bnh tiu ng tup 2: ng dng sm nht ca GLP-1 l iu tr bnh tiu ng loi 2
These medications are synthetic analogs or mimetics of human GLP-1 that resist degradation by the enzyme dipeptidyl peptidase-4 (DPP-4), allowing for prolonged therapeutic action
5-Amino-1MQ 5mg & 50mg x 10 Vials
the 3-mg dose is intended for treatment initiation and is not effective for glycemic control After 30 days on 3 mg/day: Increase to 7 mg orally once daily After 30 days on 7 mg/day: May increase dose to 14 mg orally once daily if additional glycemic control needed Note: Taking two 7-mg tablets to achieve 14 mg dose is not recommended Switching between Ozempic (SC) and Rybelsus (oral) Taking 14 mg/day orally: Transition to 0.5 mg SC once a week on the day after last oral dose Taking 0.5 mg/week SC: Transition to 7 mg or 14 mg oral starting up to 7 days after last SC injection There is no equivalent oral dose for the 1-mg SC dose Weight Management Wegovy only Indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 (obesity) or above, or 27 kg/m2 (overweight) or above in the presence of at least 1 weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, dyslipidemia) Initiate with low dose and gradually escalate to maintenance dose of 2.4 mg/week SC to minimize gastrointestinal (GI) adverse reactions If unable to tolerate a dose during escalation, consider delaying dose escalation for 4 weeks If unable to tolerate maintenance dose of 2.4 mg once-weekly, may temporarily decrease to 1.7 mg once weekly, for a maximum of 4 weeks
